279. A person may not publish an advertisement for a medicinal product unless one of the following is in force for the product—
(a)a marketing authorisation;
(b)a certificate of registration;
(c)a traditional herbal registration; or
(d)an Article 126a authorisation.
280.—(1) A person may not publish an advertisement for a medicinal product with a marketing authorisation, traditional herbal registration or Article 126a authorisation unless the advertisement complies with the particulars listed in the summary of the product characteristics.
(2) A person may not publish an advertisement for a medicinal product unless the advertisement encourages the rational use of the product by presenting it objectively and without exaggerating its properties.
(3) A person may not publish an advertisement for a medicinal product that is misleading.
281.—(1) This regulation applies to a person who holds—
(a)a marketing authorisation for a medicinal product;
(b)a certificate of registration for a medicinal product;
(c)a traditional herbal registration for a medicinal product; or
(d)an Article 126a authorisation for a medicinal product.
(2) The person must establish a scientific service to compile and collate all information relating to the product (whether received from medical sales representatives employed by that person or from any other source).
(3) The person must ensure that any medical sales representative who promotes the product is given sufficient training, and has sufficient scientific knowledge, to enable the representative to provide information about the product that is as precise and complete as possible.
(4) The person must retain—
(a)a sample of any advertisement for which the person is responsible relating to the product; and
(b)a statement indicating the persons to whom the advertisement is addressed, the method of its publication and the date when it was first published.
(5) The person must, if required to do so by notice given to the person by the Ministers, within the period specified in that notice—
(a)provide a copy of the sample and statement mentioned in paragraph (4) to the Ministers;
(b)supply such other information as the Ministers may request for the purposes of their functions under this Part; or
(c)provide such assistance as the Ministers may request for those purposes.
282. Regulations 283 (products for the purpose of inducing abortions) to 292 (exception for approved vaccination campaigns) apply to advertisements wholly or mainly directed at members of the public
283. A person may not publish an advertisement that is likely to lead to the use of a medicinal product for the purpose of inducing an abortion.
284.—(1) A person may not publish an advertisement that is likely to lead to the use of a prescription only medicine.
(2) This regulation is subject to regulation 292 (exception for approved vaccination campaigns).
285.—(1) A person may not publish an advertisement relating to a medicinal product that—
(a)contains a substance which is listed in any of Schedules I, II or IV to the Narcotic Drugs Convention (where the product is not a preparation listed in Schedule III to that Convention); or
(b)contains a substance which is listed in any of Schedules I to IV to the Psychotropic Substances Convention (where the product is not a preparation which may be exempted from measures of control in accordance with paragraphs 2 and 3 of article 3 of that Convention).
(2) This regulation is subject to regulation 292 (exception for approved vaccination campaigns).
286.—(1) A person may not publish an advertisement relating to a medicinal product that states, or implies, that a medical consultation or surgical operation is unnecessary.
(2) A person may not, in particular, publish an advertisement relating to a medicinal product that offers to provide a diagnosis or suggest a treatment by post or by means of an electronic communications network within the meaning of the Communications Act 2003.
(3) A person may not publish an advertisement relating to a medicinal product that might, by a description or detailed representation of a case history, lead to erroneous self-diagnosis.
287.—(1) A person may not publish an advertisement relating to a medicinal product that suggests that the effects of taking the medicinal product—
(a)are guaranteed;
(b)are better than or equivalent to those of another identifiable treatment or medicinal product; or
(c)are not accompanied by any adverse reaction.
(2) A person may not publish an advertisement relating to a medicinal product that uses in terms that are misleading or likely to cause alarm pictorial representations of—
(a)changes in the human body caused by disease or injury; or
(b)the action of the medicinal product on the human body.
(3) A person may not publish an advertisement relating to a medicinal product that refers in terms that are misleading or likely to cause alarm to claims of recovery.
(4) A person may not publish an advertisement relating to a medicinal product that suggests that—
(a)the health of a person who is not suffering from any disease or injury could be enhanced by taking the medicinal product; or
(b)the health of a person could be affected by not taking the medicinal product.
(5) Paragraph (4)(b) is subject to regulation 292 (exception for approved vaccination campaigns).
288. A person may not publish an advertisement relating to a medicinal product that suggests that—
(a)it is a foodstuff, cosmetic or other consumer product that is not a medicinal product; or
(b)its safety or efficacy is due to the fact that it is natural.
289. A person may not publish an advertisement relating to a medicinal product that refers to a recommendation by—
(a)scientists;
(b)health care professionals; or
(c)persons who because of their celebrity could encourage use of the medicinal product.
290. A person may not publish an advertisement relating to a medicinal product that contains any material that is directed principally at children.
291.—(1) A person may not publish an advertisement relating to a medicinal product unless it is presented so that—
(a)it is clear that it is an advertisement; and
(b)the product is clearly identified as a medicinal product.
(2) A person may not publish an advertisement relating to a medicinal product unless it includes—
(a)the name of the medicinal product;
(b)if the medicinal product contains only one active ingredient, the common name of the active ingredient;
(c)the information necessary for the correct use of the medicinal product; and
(d)an express and clear invitation to read carefully the instructions on the package or in the package leaflet (as the case may be).
(3) This regulation is subject to regulation 296 (exception for advertisements intended as a reminder).
(4) Paragraph (2) is subject to regulation 301 (advertisements for registered homoeopathic medicinal products).
292. Regulations 284 (prescription only medicines), 285 (narcotic and psychotropic substances) and 287(4)(b) (material about effects of medicinal products) do not apply to an advertisement as part of a vaccination campaign that—
(a)relates to a medicinal product that is a vaccine or serum; and
(b)has been approved by the Ministers.
293.—(1) The holder of a marketing authorisation, certificate of registration, traditional herbal registration or Article 126a authorisation may not sell or supply a medicinal product for a promotional purpose to a person who is not qualified to prescribe medicinal products.
(2) A person who carries on a medicines business may not sell or supply a medicinal product for a promotional purpose to a person who is not qualified to prescribe medicinal products.
(3) This regulation applies regardless of whether the promotional purpose is that of the seller or supplier or of a third party.
(4) In this regulation “medicines business” means a business that consists in whole or in part of manufacturing, selling or supplying medicinal products.
294.—(1) This regulation applies to an advertisement that—
(a)relates to a medicinal product; and
(b)is wholly or mainly directed at persons qualified to prescribe or supply such products.
(2) A person may not publish an advertisement to which this regulation applies unless—
(a)subject to paragraph (3), it contains the particulars set out in paragraphs 1 to 8 of Schedule 30; and
(b)in the case of a written advertisement, it is in accordance with paragraph 9 of that Schedule.
(3) In the case of an advertisement that is not a written advertisement, those particulars may alternatively be made available in written form to all persons to whom the advertisement is made available.
(4) This regulation—
(a)does not apply to an advertisement to which regulation 295 (abbreviated advertisements) applies;
(b)does not apply to oral representations made by medical sales representatives to which regulation 299 (medical sales representatives) applies; and
(c)is subject to regulations 296 (exception for advertisements intended as a reminder) and 301 (advertisements for registered homoeopathic medicinal products).
295.—(1) This regulation applies to an abbreviated advertisement that—
(a)relates to a medicinal product; and
(b)is wholly or mainly directed at persons qualified to prescribe or supply such products.
(2) A person may not issue an abbreviated advertisement to which this regulation applies unless it contains—
(a)the particulars set out in paragraphs 2 to 6 of Schedule 30 (particulars for advertisements to persons qualified to prescribe or supply);
(b)the statement “Information about this product, including adverse reactions, precautions, contra-indications, and method of use can be found at:”; accompanied by
(c)a web site address that corresponds to that statement; and
(d)the name and address of the holder of the marketing authorisation, certificate of registration, traditional herbal registration or Article 126a authorisation for the medicinal product, or the business name and address of the part of the holder’s business that is responsible for its sale or supply.
(3) The web site at the address mentioned in sub-paragraph (2)(c) must make available—
(a)the particulars set out in Schedule 30; or
(b)a copy of the summary of the product characteristics.
(4) In this regulation, “abbreviated advertisement” means an advertisement, other than a loose insert, that—
(a)does not exceed 420 square centimetres in size; and
(b)appears in a publication sent or delivered wholly or mainly to persons qualified to prescribe or supply medicinal products.
(5) This regulation is subject to regulation 301 (advertisements for registered homoeopathic medicinal products).
296. Regulations 291 (form and content of advertisement) and 294 (general requirements) do not apply to an advertisement relating to a medicinal product if the advertisement is intended solely as a reminder of the product and consists solely of—
(a)in the case of a product other than a homoeopathic medicinal product to which a certificate of registration relates, its name, international non-proprietary name or trademark; and
(b)in the case of a homoeopathic medicinal product to which a certificate of registration relates, its name, international non-proprietary name, invented name or trademark or the scientific name of the stock or stocks from which it is derived.
297.—(1) A person may not as part of the promotion of a medicinal product send or deliver any written material to a person qualified to prescribe or supply medicinal products unless the material—
(a)contains particulars in accordance with all the paragraphs of Schedule 30; and
(b)states the date on which it was drawn up or last revised.
(2) A person may not include any information in written material to which paragraph (1) applies unless it—
(a)is accurate;
(b)is up-to-date;
(c)can be verified; and
(d)is sufficiently complete to enable the recipient to form an opinion of the therapeutic value of the product to which it relates.
(3) A person may not include any illustrative material in written material to which paragraph (1) applies unless—
(a)the illustrative material is accurately reproduced; and
(b)the written material indicates the precise source of the illustrative material.
(4) In this regulation “illustrative material” means a quotation, table or any other illustrative material taken from a medical journal or other scientific work.
298.—(1) A person (“the supplier”) may not supply a free sample of a medicinal product to another person (“the recipient”) unless the following conditions are met.
(2) Condition A is that the recipient—
(a)is qualified to prescribe medicinal products; and
(b)receives the sample for the purpose of acquiring experience in dealing with the product in question.
(3) Condition B is that the sample is supplied to the recipient—
(a)on an exceptional basis; and
(b)in response to a request from, and signed and dated by, the recipient.
(4) Condition C is that, taking the year in which the sample is supplied as a whole, only a limited number of samples of the product in question are supplied to the recipient in that year.
(5) Condition D is that the sample—
(a)is no larger than the smallest presentation of the product that is available for sale in the United Kingdom;
(b)is marked “free medical sample – not for resale” or bears a similar description; and
(c)is accompanied by a copy of the summary of the product characteristics.
(6) Condition E is that the sample does not contain—
(a)a substance which is listed in any of Schedules I, II or IV to the Narcotic Drugs Convention (where the product is not a preparation listed in Schedule III to that Convention); or
(b)a substance which is listed in any of Schedules I to IV to the Psychotropic Substances Convention (where the product is not a preparation which may be exempted from measures of control in accordance with paragraphs 2 and 3 of article 3 of that Convention).
(7) Condition F is that the supplier maintains an adequate system of control and accountability in relation to the supply of free samples.
299.—(1) This regulation applies in relation to the promotion by a medical sales representative of medicinal products to persons qualified to prescribe or supply such products.
(2) During each visit for promotional purposes the representative must give to, or have available for, each person visited a copy of the summary of the product characteristics for each product promoted.
(3) The representative must report all information, with particular reference to any adverse reactions, that—
(a)is received from persons visited for promotional purposes; and
(b)relates to the use of a product promoted,
to the scientific service established in accordance with regulation 281(2) by the holder of the marketing authorisation, certificate of registration, traditional herbal registration or Article 126a authorisation for the product.
300.—(1) A person may not, in connection with the promotion of medicinal products to persons qualified to prescribe or supply them, supply, offer, or promise any gift, pecuniary advantage or benefit unless it is—
(a)inexpensive; and
(b)relevant to the practice of medicine or pharmacy.
(2) A person may not provide hospitality at a meeting or event held for the purposes of the promotion of a medicinal product unless—
(a)the hospitality is strictly limited to the main purposes of the meeting or event; and
(b)the person to whom it is provided or offered is a health care professional.
(3) Nothing in this regulation shall prevent any person providing hospitality at an event held for purely professional or scientific purposes provided that—
(a)the hospitality is strictly limited to the main scientific objective of the event; and
(b)the person to whom it is provided or offered is a health care professional.
(4) A person qualified to prescribe or supply medicinal products may not solicit or accept any gift, pecuniary advantage, benefit or hospitality that is prohibited by this regulation.
(5) In this regulation “hospitality” includes—
(a)sponsorship of a person’s attendance at a meeting or event; and
(b)the payment of travelling or accommodation expenses.
(6) This regulation does not apply in relation to measures or trade practices relating to prices, margins or discounts that were in existence on 1st January 1993.
301.—(1) A person may not publish an advertisement relating to a homoeopathic medicinal product to which a certificate of registration relates unless the advertisement meets the following conditions.
(2) Condition A is that the advertisement does not mention any specific therapeutic indications.
(3) Condition B is that the advertisement does not contain any details other than those mentioned in Schedule 28 (labelling requirements for registrable homoeopathic medicinal products).
(4) Nothing in regulation 291(2) (form and content of advertisement), 294 (general requirements) or 295 (abbreviated advertisements) requires an advertisement relating to a homoeopathic medicinal product to which a certificate of registration relates to contain any detail not specified in Schedule 28.
302. A person may not publish an advertisement relating to a herbal medicinal product to which a traditional herbal registration relates unless it contains—
(a)the words “Traditional herbal medicinal product for use in”; followed by
(b)a statement of one or more therapeutic indications for the product consistent with the terms of the registration; followed by
(c)the words “exclusively based on long standing use”.
303.—(1) A person is guilty of an offence if that person commits a breach of a provision in this Chapter.
(2) A breach of a provision in this Chapter includes any—
(a)contravention by any person of any prohibition in this Chapter; and
(b)failure by any person to comply with any requirement or obligation in this Chapter.
(3) A person guilty of an offence under this regulation other than one to which paragraph (4) applies is liable—
(a)on summary conviction to a fine not exceeding the statutory maximum; or
(b)on conviction on indictment to a fine, to imprisonment for a term not exceeding two years or to both.
(4) This paragraph applies to an offence consisting of a breach of—
(a)regulation 298(1) (free samples);
(b)regulation 299(2) or (3) (medical sales representatives); or
(c)regulation 300(4) (solicitation or acceptance of inducements or hospitality).
(5) A person guilty of an offence to which paragraph (4) applies is liable on summary conviction to a fine not exceeding level 5 on the standard scale.